Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region

Virology

Volumn 301, Issue 1, 2002, Pages 99-108

  Toth, Karoly ^a   Kuppuswamy, Mohan ^a   Doronin, Konstantin ^a   Doronina, Oksana A ^a   Lichtenstein, Drew L ^a   Tollefson, Ann E ^a   Wold, William S M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; EPIDERMAL GROWTH FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS PROTEIN; VIRUS VECTOR;

APOPTOSIS; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DEFECTIVE VIRUS; GENE DELETION; GENETIC TRANSFECTION; LYSOSOME; MEDICAL RESEARCH; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; VIRUS CHARACTERIZATION; VIRUS EXPRESSION; VIRUS MUTANT; VIRUS REPLICATION;

ADENOVIRIDAE; CYTOMEGALOVIRUS;

EID: 0036398118     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1580     Document Type: Article

References (78)

1. Andersson, M., McMichael, A., and Peterson, P. A. (1987). Reduced allorecognition of adenovirus-2 infected cells. J. Immunol. 138, 3960-3966.
2. Andersson, M., Paabo, S., Nilsson, T., and Peterson, P. A. (1985). Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43, 215-222.
3. Benedict, C., Norris, P., Prigozy, T., Bodmer, J. L., Mahr, J. A., Garnett, C., Martinon, F., Tschopp, J., Gooding, L. R., and Ware, C. F. (2001). Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. J. Biol. Chem. 276, 3270-3278.
4. Bennett, E. M., Bennink, J. R., Yewdell, J. W., and Brodsky, F. M. (1999). Cutting Edge: Adenovirus E19 has two mechanisms for affecting class I MHC expression. J. Immunol. 162, 5049-5052.
5. Blair, G. E., and Hall, K. T. (1998). Human adenoviruses: Evading detection by cytotoxic T lymphocytes. Semin. Virol. 8, 387-397.
6. Brady, H. A., Scaria, A., and Wold, W. S. M. (1992). Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus. J. Virol. 66, 5914-5923.
7. Bruder, J. B., and Kovesdi, I. (1997). Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J. Virol. 71, 398-404.
8. Burgert, H. G., and Kvist, S. (1985). An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41, 987-997.
9. Burgert, H. G., Maryanski, J. L., and Kvist, S. (1987). "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc. Natl. Acad. Sci. USA 84, 1356-1360.
10. Carlin, C. R., Tollefson, A. E., Brady, H. A., Hoffman, B. L., and Wold, W. S. M. (1989). Epidermal growth factor receptor is down-regulated by a 10, 400 MW protein encoded by the E3 region of adenovirus. Cell 57, 135-144.
11. Cathomen, T., and Weitzman, M. D. (2000). A functional complex of adenovirus proteins E1B-55kDa and E4orf6 is necessary to modulate the expression level of p53 but not its transcriptional activity. J. Virol. 74, 11407-11412.
12. Chen, P., Tian, J., Kovesdi, I., and Bruder, J. B. (1998). Interaction of the adenovirus 14.7K protein with FLICE inhibits Fas ligand-induced apoptosis. J. Biol. Chem. 273, 5815-5820.
13. Chinnadurai, G. (1998). Control of apoptosis by human adenovirus genes. Semin. Virol. 8, 399-408.
14. Cladaras, C., Bhat, B., and Wold, W. S. (1985). Mapping the 5′ ends, 3′ ends, and splice sites of mRNAs from the early E3 transcription unit of adenovirus 5. Virology 140, 44-54.
15. Cladaras, C., and Wold, W. S. (1985). DNA sequence of the early E3 transcription unit of adenovirus 5. Virology 140, 28-43.
16. 2 to membranes. J. Virol. 71, 2830-2837.
17. Elsing, A., and Burgert, H.-G. (1998). The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc. Natl. Acad. Sci. USA 95, 10072-10077.
18. Gooding, L. R., Aquino, L., Duerksen-Hughes, P. J., Day, D., Horton, T. M., Yei, S. P., and Wold, W. S. M. (1991a). The E1B 19, 000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells. J. Virol. 65, 3083-3094.
19. Gooding, L. R., Elmore, L. W., Tollefson, A. E., Brady, H. A., and Wold, W. S. M. (1988). A 14, 700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53, 341-346.
20. Gooding, L. R., Ranheim, T. S., Tollefson, A. E., Aquino, L., Duerksen-Hughes, P., Horton, T. M., and Wold, W. S. M. (1991b). The 10, 400- and 14, 500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J. Virol. 65, 4114-4123.
21. Gooding, L. R., Sofola, I. O., Tollefson, A. E., Duerksen-Hughes, P., and Wold, W. S. M. (1990). The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. J. Immunol. 145, 3080-3086.
22. Harrod, K. S., Hermiston, T. W., Trapnell, B. C., Wold, W. S. M., and Whitsett, J. A. (1998). Lung-specific expression of E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression. Hum. Gene Ther. 9, 1885-1898.
23. Hashimoto, S., Ishii, A., and Yonehara, S. (1991). The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int. Immunol. 3, 343-351.
24. Hermiston, T. W., Tripp, R. A., Sparer, T., Gooding, L. R., and Wold, W. S. M. (1993). Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: Identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. J. Virol. 67, 5289-5298.
25. Hoffman, P., Yaffe, M. B., Hoffman, B. L., Yei, S., Wold, W. S. M., and Carlin, C. (1992). Characterization of the adenovirus E3 protein that down-regulates the epidermal growth factor receptor. Evidence for intermolecular disulfide bonding and plasma membrane localization. J. Biol. Chem. 267, 13480-13487.
26. Horton, T. M., Ranheim, T. S., Aquino, L., Kusher, D. I., Saha, S. K., Ware, C. F., Wold, W. S. M., and Gooding, L. R. (1991). Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis. J. Virol. 65, 2629-2639.
27. Horton, T. M., Tollefson, A. E., Wold, W. S. M., and Gooding, L. R. (1990). A protein serologically and functionally related to the group C E3 14, 700-kilodalton protein is found in multiple adenovirus serotypes. J. Virol. 64, 1250-1255.
28. Horwitz, M. (2001). Adenovirus immunoregulatory genes and their cellular targets. Virology 279, 1-8.
29. Jackson, M. R., Nilsson, T., and Peterson, P. A. (1990). Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9, 3153-3162.
30. Krajcsi, P., Dimitrov, T., Hermiston, T. W., Tollefson, A. E., Ranheim, T. S., Vande Pol, S. B., Stephenson, A. H., and Wold, W. S. M. (1996). The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J. Virol. 70, 4904-4913.
31. cyt orientation. Virology 187, 131-144.
32. Krajcsi, P., Tollefson, A. E., Anderson, C. W., and Wold, W. S. M. (1992b). The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm. J. Virol. 66, 1665-1673.
33. Krajcsi, P., Tollefson, A. E., and Wold, W. S. M. (1992c). The E3-14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O-glycosylated but not N-glycosylated. Virology 188, 570-579.
34. Krajcsi, P., and Wold, W. S. M. (1992). The adenovirus E3-14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserine. Virology 187, 492-498.
35. Krajcsi, P., and Wold, W. S. M. (1998). Viral proteins that regulate cellular signalling. J. Gen. Virol. 79, 1323-1335.
36. Kuivinen, E., Hoffman, B. L., Hoffman, P. A., and Carlin, C. R. (1993). Structurally related class I and class II receptor protein tyrosine kinases are down-regulated by the same E3 protein coded for by human group C adenoviruses. J. Cell. Biol. 120, 1271-1279.
37. Leonard, G. T., and Sen, G. C. (1996). Effects of adenovirus E1A protein on interferon-signaling. Virology 224, 25-33.
38. Li, Y., Kang, J., Friedman, J., Tarassishin, L., Ye, J., Kovalenko, A., Wallach, D., and Horwitz, M. S. (1999). Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis. Proc. Natl. Acad. Sci. USA 96, 1042-1047.
39. Li, Y., Kang, J., and Horwitz, M. S. (1997). Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers. J. Virol. 71, 1576-1582.
40. Li, Y., Kang, J., and Horwitz, M. S. (1998). Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol. Cell. Biol. 18, 1601-1610.
41. Lukashok, S., Tarassishin, L., Li, Y., and Horwitz, M. (2000). An adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis complexes with dynein and a small GTPase. J. Virol. 74, 4705-4709.
42. Mahr, J. A., and Gooding, L. R. (1999). Immune evasion by adenoviruses. Immunol. Rev. 168, 121-130.
43. Mathews, M. B., and Shenk, T. (1991). Adenovirus virus-associated RNA and translation control. J. Virol. 65, 5657-5662.
44. Montell, C., Courtois, G., Eng, C., and Berk, A. (1984). Complete transformation by adenovirus 2 requires both E1A proteins. Cell 36, 951-961.
45. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
46. Nevels, M., Rubenwolf, S., Spruss, T., Wolf, H., and Dobner, T. (2000). Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein. J. Virol. 74, 5168-5181.
47. Paabo, S., Bhat, B. M., Wold, W. S. M., and Peterson, P. A. (1987). A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum. Cell 50, 311-317.
48. Perez, D., and White, E. (2000). TNFα signals apoptosis through a Bid-dependent conformational change in bax that is inhibited by E1B 19K. Mol. Cell 6, 53-63.
49. Querido, E., Morison, M., Chu-Pham-Dang, H., Thirlwell, S. W. L., Boivin, D., and Branton, P. (2001). Identification of three functions of the adenovirus E4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex. J. Virol. 75, 699-709.
50. Ranheim, T. S., Shisler, J., Horton, T. M., Wold, L. J., Gooding, L. R., and Wold, W. S. M. (1993). Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. J. Virol. 67, 2159-2167.
51. Rawle, F. C., Tollefson, A. E., Wold, W. S. M., and Gooding, L. R. (1989). Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K. J. Immunol. 143, 2031-2037.
52. Routes, J. M., Li, H., Bayley, S. T., and Ryan, S. K. D. J. (1996). Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding. J. Immunol. 156, 1055-1061.
53. Scaria, A., and Wold, W. S. M. (1994). Fine-mapping of sequences that suppress splicing in the E3 complex transcription unit of adenovirus. Virology 205, 406-416.
54. Schlessinger, J. (2000). Cell signaling by receptor tyrosine kinases. Cell 103, 211-214.
55. Shen, Y., and White, E. (2001). p53-dependent apoptosis pathways. Adv. Cancer Res. 82, 55-84.
56. Shisler, J., Yang, C., Walter, B., Ware, C. F., and Gooding, L. R. (1997). The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J. Virol. 71, 8299-8306.
57. Stewart, A. R., Tollefson, A. E., Krajcsi, P., Yei, S. P., and Wold, W. S. M. (1995). The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane. J. Virol. 69, 172-181.
58. Strasser, A., Harris, A. W., Huang, D. C. S., Krammer, P. H., and Cory, S. (1995). Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147.
59. Sundararajan, R., Cuconati, A., Nelson, D., and White, E. (2001). TNF-alpha induces Bax-Bax interaction and apoptosis which is inhibited by adenovirus E1B 19K. J. Biol. Chem. 276, 45120-45127.
60. Sundararajan, R., and White, E. (2001). E1B blocks bax oligomerization and tumor necrosis factor alpha-mediated apoptosis. J. Virol. 75, 7506-7516.
61. Teodoro, J. G., and Branton, P. E. (1997). Regulation of apoptosis by viral gene products. J. Virol. 71, 1739-1746.
62. Tollefson, A. E., Hermiston, T. W., Lichtenstein, D. L., Colle, C. F., Tripp, R. A., Dimitrov, T., Toth, K., Wells, C. E., Doherty, P. C., and Wold, W. S. M. (1998). Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392, 726-730.
63. Tollefson, A. E., Krajcsi, P., Pursley, M. H., Gooding, L. R., and Wold, W. S. M. (1990a). A 14, 500 MW protein is coded by region E3 of group C human adenoviruses. Virology 175, 19-29.
64. Tollefson, A. E., Krajcsi, P., Yei, S. P., Carlin, C. R., and Wold, W. S. M. (1990b). A 10, 400-molecular-weight membrane protein is coded by region E3 of adenovirus. J. Virol. 64 794-801.
65. Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryerse, J. S., Wold, L. J., and Wold, W. S. M. (1996). The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J. Virol. 70, 2296-2306.
66. Tollefson, A. E., Stewart, A. R., Yei, S. P., Saha, S. K., and Wold, W. S. M. (1991). The 10, 400- and 14, 500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. J. Virol. 65, 3095-3105.
67. Tollefson, A. E., Toth, K., Doronin, K., Kuppuswamy, M., Doronina, O. A., Lichtenstein, D. L., Hermiston, T. W., Smith, C. A., and Wold, W. S. M. (2001). Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. J. Virol. 75, 8875-8887.
68. Tollefson, A. E., and Wold, W. S. M. (1988). Identification and gene mapping of a 14, 700-molecular-weight protein encoded by region E3 of group C adenoviruses. J. Virol. 62, 33-39.
69. Vogelstein, B., Lane, D., and Levine, A. J. (2000). Surfing the p53 network. Nature 408, 307-310.
70. Walczak, H., and Krammer, P. H. (2000). The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis system. Exp. Cell Res. 256, 58-66.
71. White, E. (1998). Regulation of apoptosis by adenovirus E1A and E1B oncogenes. Semin. Virol. 8, 505-513.
72. White, E., Sabbatini, P., Debbas, M., Wold, W. S. M., Kusher, D. I., and Gooding, L. R. (1992). The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Mol. Cell. Biol. 12, 2570-2580.
73. Wold, W. S. M., and Chinnadurai, G. (2000). Adenovirus proteins that regulate apoptosis. In "DNA Virus Replication: Frontiers in Molecular Biology" (A. J. Cann, Ed.), pp. 200-232. Oxford Univ. Press, Oxford.
74. Wold, W. S. M., Deutscher, S. L., Takemori, N., Bhat, B. M., and Magie, S. C. (1986). Evidence that AGUA 3 UAUGA and CCA 3 AGAUGA initiate translation in the same mRNA region E3 of adenovirus. Virology 148, 168-180.
75. Wold, W. S. M., Doronin, K., Toth, K., Kuppuswamy, M., Lichtenstein, D. L., and Tollefson, A. E. (1999). Immune responses to adenoviruses: Viral evasion mechanisms and their implications for the clinic. Curr. Opinion Immunol. 11, 380-386.
76. Wold, W. S. M., and Tollefson, A. E. (1998). Adenovirus E3 proteins: 14.7K, RID, and gp19K inhibit immune-induced cell death; adenovirus death protein promotes cell death. Semin. Virol. 8, 515-523.
77. Wold, W. S. M., Tollefson, A. E., and Hermiston, T. W. (1995). E3 transcription unit of adenovirus. In "The Molecular Repertoire of Adenoviruses" (W. Doerfler and P. Bohm, Eds.), pp. 237-274. Springer-Verlag, Heidelberg.
78. Ye, J., Xie, X., Tarassishin, L., and Horwitz, M. (2000). Regulation of the NF-κB activation pathway by isolated domains of FIP3/IKKγ, a component of the IκB-α kinase complex. J. Biol. Chem. 275, 9882-9889.